Roche & Zealand Pharma Partner to Co-Develop Petrelintide as a Breakthrough Obesity Therapy Basel, 12 March 2025 – Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma (a Danish biotechnology research company) to co-develop and co-commercialise Zealand Pharma’s amylin
Psychobiotics and Mental Health: A Deep Dive with Sarunas Baciliunas The intricate relationship between the gut and brain has become a focal point of scientific inquiry, revealing profound implications for mental health. As research advances, the field of psychobiotics—probiotics
EDX Medical Develops Groundbreaking ‘Super Test’ for Prostate Cancer with 100+ Biomarker Analysis and 99% Accuracy The most accurate and sensitive screening test available and will be transformative in tackling prostate cancer in men who may have no idea if anything is wrong with them.
Unilabs Expands AI in Medical Imaging with Oxipit’s Chest X-Ray Solution Geneva, February 17, 2025: Unilabs, a top diagnostic services provider in Europe, has partnered with Oxipit, a leading medical imaging AI company, to implement AI-powered chest X-ray solutions across its
Backed by Top Investors, DeepMind Alumni Raise $50M to Develop AI-Driven Protein Engineering Latent Labs, a pioneering AI-driven biotech startup, has secured $50 million in funding to transform how proteins are designed. Latent Labs is at the forefront of an industry shift where scientists no longer just study biology, they program it.
5 UK Biotech Companies Expanding the Boundaries of Science & Medicine The UK has firmly established itself as a global innovator. With remarkable progress in bioscience advancements and bio-pharma developments, the country continues to push the limits of what’s possible in modern healthcare.
Microfluidics and the Future of Diagnostics: Insights from Paul Marshall Microfluidics is reshaping diagnostics, offering faster, more precise, and cost-effective solutions. However, the journey from breakthrough research to real-world applications comes with significant challenges. In a recent interview, Paul Marshall,
NHS to Launch World’s Largest AI Trial to Revolutionise Breast Cancer Detection The £11 million government-funded trial, announced on World Cancer Day, will determine whether AI can analyse mammograms as accurately as human radiologists. If it proves successful, hospitals could cut their workload by 50% and speed up life-saving diagnoses.
UK Biotech Investment Soars to £3.5bn in 2024, Reports BIA 01 Feb 2025: According to the BioIndustry Association’s (BIA) annual financing report, the UK biotech sector raised £3.5 billion in 2024, marking a 94% increase from the previous
Transforming Patient Care with Biomaterials: A conversation with Nihal Engin Vrana The intersection of biomaterials and personalised medicine is redefining the future of healthcare, unlocking new possibilities for treatment and recovery. From life-changing implantable devices to cutting-edge regenerative therapies, innovation in
Cultivated Meat and Market Disruption: A Conversation with Yash Mishra Cultivated meat, grown directly from animal cells without the need for traditional livestock farming, represents a paradigm shift in the global food industry. In a recent interview with Muhammad Younis,
Interview with Nava Whiteford: Insights into Nanopore Sequencing and Its Unique Edge In a recent interview with Nava Whiteford, Consultant at Whiteford Research Limited, we delved into what sets nanopore sequencing apart from other available sequencing technologies. He shared valuable insights with
Advancing Sustainable Agriculture - Interview with Nina Vinot on the Role of Microbiome Innovations In a recent interview, Nina Vinot, Director of Business Development at Cybele Agrocare, and Business Development, Bioprox Healthcare, discussed with Muhammad Younis how innovations in microbiome science are transforming agriculture.
UK and Switzerland Collaborate with £16 Million Investment in Joint Projects and Clinical Trials 09 December, 2024: In a major step forward for international scientific cooperation, Switzerland and the UK have updated their landmark science and research agreement, committing £16 million to support joint